Krimish Bhagat
Physician Assistant · Hampstead
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Greater Hampstead Family Medicine Inc · 30 clinicians in this group
Hospitals listed: Merrimack Health Methuen Hospital · Parkland Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Krimish Bhagat’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Holy Family HospitalMethuen, MAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Steward Health Care System, which runs 36 hospitals in 8 statesPatients rate it 2 of 5 · 53% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.368, Oct 2024 – Sep 2025
- Parkland Medical CenterDerry, NHAcute Care Hospital · Proprietary · Has an emergency departmentPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Holy Family Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 3 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.368 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.94) · 800 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.61 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.59 (104.29 to 230.88) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 151 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 370 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 1,508 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 6,142 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.46) · 6,115 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.62 (0.33 to 4.91) · 731 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 127 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.97 (0.38 to 3.56) · 749 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.95 (3.56 to 22.34) · 124 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.84 (1.62 to 10.06) · 120 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.18 to 3.16) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.17) · 4,734 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.707 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.878 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.599 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 63 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 464 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 16 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 10.4 · 439 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.5 · 541 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 497 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.2 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.6 (8.9 to 15.3) · 1,396 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 202 cases | No different | Jan 2024 – Dec 2024 |
What patients said (551 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 50% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 53% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Parkland Medical Center
Behind the star rating — Deaths: 2 better, 4 the same, 0 worse of 6 measures. Safety: 1 better, 2 the same, 0 worse of 3 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 261 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.43 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 274 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 307 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,272 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,747 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,696 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.61 to 5.58) · 269 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.4) · 43 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.53 to 3.92) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.91 (0 to 18.84) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.16 (0.85 to 9.47) · 36 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 67 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 1.35) · 2,043 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.349 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 86 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 324 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 85 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -16.7 · 306 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28 · 314 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 339 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.6 to 8.5) · 63 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.9 to 15.4) · 63 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9.2 to 15.8) · 725 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 128 cases | No different | Jan 2024 – Dec 2024 |
What patients said (503 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$109,863
Medicare paid this office $109,863 for 274 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 189 | $27,354 | $80 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 73 | $18,553 | $42 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $12,409 | $110 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 60 | $9,766 | $33 |
| Long return visit (40+ min) | 54 | $9,115 | $120 |
See all 21 services
| Return visit (30+ min) | 189 | $27,354 | $80 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 73 | $18,553 | $42 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 113 | $12,409 | $110 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 60 | $9,766 | $33 |
| Long return visit (40+ min) | 54 | $9,115 | $120 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 53 | $8,756 | $32 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 47 | $3,818 | $32 |
| Short return visit (20+ min) | 53 | $3,337 | $55 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $3,280 | $62 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 36 | $2,463 | $26 |
| Annual depression screening, 5 to 15 minutes | 60 | $968 | $16 |
| Insertion of needle into vein for collection of blood sample | 56 | $718 | $9 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 49 | $667 | $11 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 51 | $644 | $12 |
| Blood test, lipids (cholesterol and triglycerides) | 37 | $485 | $13 |
| Annual alcohol misuse screening, 5 to 15 minutes | 22 | $346 | $16 |
| Assessment of emotional or behavioral problems | 65 | $258 | $4 |
| Hemoglobin a1c level | 16 | $152 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $106 | $9 |
| Blood glucose (sugar) test performed by hand-held instrument | 25 | $80 | $3 |
| Automated urinalysis test | 19 | $46 | $2 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
274 Original Medicare patients in 2024. Average age 74 · Women 36% · Health risk score 1.05. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 27% · Coronary heart disease 25% · Atrial fibrillation 20% · Chronic kidney disease 17% · COPD 17% · Cancer 16% · Heart failure 12% · Depression 12% · Stroke 6% · Dementia 5%.
The office billed $341,641, Medicare allowed $137,781 and paid $109,863; for 2,452 services of 47 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 274 | 2,452 | 74 | 1.05 | $341,641 | $109,863 |
| 2022 | 13 | 13 | 70 | 0.81 | $1,288 | $440 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$4,092 in 2024
Medicaid paid $4,092 for 74 billed services this clinician did in 2024, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| HOME/RES VISIT EST PATIENT MOD MDM 40 MINUTES | 42 | $3,626 |
| Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels) | 12 | $465 |
| HOME/RES VISIT EST PATIENT HIGH MDM 60 MINUTES | 20 | $0 |
| 2024 | 74 | 3 | 30 | $4,092 |
Drugs they prescribed that Part D paid
$387,091
Pharmacies billed $387,091 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (31 of 4,715) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
4,301 generic and 401 brand-name prescriptions · $387,091 in drug cost · 167 antibiotic prescriptions to 109 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 46 | $59,251 | $1,288 |
| Eliquis | 45 | $58,259 | $1,295 |
| Ozempic | 28 | $46,166 | $1,649 |
| Trelegy Ellipta | 27 | $37,783 | $1,399 |
| Xarelto | 27 | $28,589 | $1,059 |
See all 81 drugs
| Mounjaro | 46 | $59,251 | $1,288 |
| Eliquis | 45 | $58,259 | $1,295 |
| Ozempic | 28 | $46,166 | $1,649 |
| Trelegy Ellipta | 27 | $37,783 | $1,399 |
| Xarelto | 27 | $28,589 | $1,059 |
| Farxiga | 23 | $24,485 | $1,065 |
| Januvia | 11 | $10,841 | $986 |
| Atorvastatin | 396 | $3,403 | $9 |
| Colestipol | 18 | $2,406 | $134 |
| Ezetimibe | 60 | $2,238 | $37 |
| Metoprolol | 160 | $2,196 | $14 |
| Lisinopril | 245 | $1,642 | $7 |
| Rosuvastatin | 105 | $1,582 | $15 |
| Omeprazole | 121 | $1,532 | $13 |
| Gabapentin | 81 | $1,510 | $19 |
| Pravastatin | 97 | $1,197 | $12 |
| Amlodipine Besylate | 183 | $1,170 | $6 |
| Levothyroxine | 117 | $1,150 | $10 |
| Benazepril | 122 | $1,051 | $9 |
| Dextroamphetamine-Amphet Er | 15 | $1,025 | $68 |
| Candesartan Cilexetil | 12 | $972 | $81 |
| Fenofibrate | 20 | $964 | $48 |
| Metformin Hcl Er | 88 | $956 | $11 |
| Pantoprazole | 85 | $903 | $11 |
| Albuterol Sulfate Hfa | 58 | $894 | $15 |
| Clopidogrel | 40 | $830 | $21 |
| Potassium Chloride | 23 | $738 | $32 |
| Montelukast | 41 | $672 | $16 |
| Trazodone | 89 | $672 | $8 |
| Losartan | 86 | $657 | $8 |
| Amoxicillin-Clavulanate Potass | 47 | $634 | $13 |
| Simvastatin | 95 | $574 | $6 |
| Allopurinol | 64 | $530 | $8 |
| Atenolol | 100 | $508 | $5 |
| Bupropion Xl | 16 | $500 | $31 |
| Metoprolol | 70 | $493 | $7 |
| Testosterone Cypionate | 17 | $484 | $28 |
| Diltiazem 24hr Er (Cd) | 17 | $469 | $28 |
| Doxycycline Hyclate | 34 | $451 | $13 |
| Metformin | 70 | $440 | $6 |
| Mirtazapine | 20 | $412 | $21 |
| Alprazolam | 79 | $371 | $5 |
| Fenofibrate | 12 | $350 | $29 |
| Hydrochlorothiazide | 128 | $346 | $3 |
| Fluticasone Propionate | 27 | $336 | $12 |
| Escitalopram | 23 | $329 | $14 |
| Balsalazide Disodium | 13 | $304 | $23 |
| Tamsulosin | 45 | $301 | $7 |
| Venlafaxine Hcl Er | 23 | $279 | $12 |
| Valsartan | 11 | $275 | $25 |
| Citalopram Hbr | 46 | $271 | $6 |
| Furosemide | 60 | $260 | $4 |
| Paroxetine | 16 | $249 | $16 |
| Warfarin | 26 | $231 | $9 |
| Lovastatin | 16 | $231 | $14 |
| Sertraline | 48 | $220 | $5 |
| Clonazepam | 27 | $184 | $7 |
| Nitroglycerin | 14 | $170 | $12 |
| Torsemide | 11 | $167 | $15 |
| Triamcinolone Acetonide | 26 | $162 | $6 |
| Carvedilol | 31 | $162 | $5 |
| Hydroxyzine | 21 | $157 | $7 |
| Famotidine | 17 | $152 | $9 |
| Finasteride | 24 | $139 | $6 |
| Tramadol | 31 | $138 | $4 |
| Ondansetron | 12 | $135 | $11 |
| Lorazepam | 37 | $135 | $4 |
| Alendronate | 29 | $128 | $4 |
| Nitrofurantoin Mono-Macro | 11 | $115 | $10 |
| Azithromycin | 29 | $101 | $3 |
| Methylprednisolone | 24 | $99 | $4 |
| Buspirone | 13 | $98 | $8 |
| Prednisone | 55 | $97 | $2 |
| Ibuprofen | 25 | $90 | $4 |
| Glimepiride | 30 | $82 | $3 |
| Cyclobenzaprine | 17 | $72 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $70 | $6 |
| Pioglitazone | 12 | $70 | $6 |
| Spironolactone | 15 | $59 | $4 |
| Sildenafil Citrate | 20 | $42 | $2 |
| Paxlovid | 16 | $0 | $0 |
Year by year
| 2024 | 4,715 | 508 | 1% (31) | 9% | $387,091 |
| 2023 | 4,040 | 530 | 1% (39) | 8% | $334,768 |
| 2022 | 3,725 | 436 | 1% (22) | 8% | $256,711 |
| 2021 | 1,860 | 307 | 1% (18) | 9% | $141,036 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 73 drugs
| Eliquis | 52 | $54,405 | $1,046 |
| Jardiance | 15 | $27,701 | $1,847 |
| Ozempic | 22 | $25,731 | $1,170 |
| Trulicity | 14 | $22,844 | $1,632 |
| Lantus Solostar | 14 | $13,229 | $945 |
| Xarelto | 12 | $12,833 | $1,069 |
| Farxiga | 12 | $9,203 | $767 |
| Symbicort | 19 | $9,169 | $483 |
| Advair Hfa | 11 | $8,946 | $813 |
| Atorvastatin | 337 | $4,565 | $14 |
| Emtricitabine-Tenofovir Disop | 11 | $3,991 | $363 |
| Colestipol | 13 | $3,219 | $248 |
| Metoprolol | 127 | $3,144 | $25 |
| Ezetimibe | 49 | $2,980 | $61 |
| Pravastatin | 109 | $2,329 | $21 |
| Metformin Hcl Er | 80 | $2,081 | $26 |
| Lisinopril | 213 | $1,968 | $9 |
| Rosuvastatin | 94 | $1,947 | $21 |
| Benazepril | 116 | $1,889 | $16 |
| Albuterol Sulfate Hfa | 48 | $1,661 | $35 |
| Levothyroxine | 104 | $1,577 | $15 |
| Amlodipine Besylate | 147 | $1,482 | $10 |
| Gabapentin | 54 | $1,418 | $26 |
| Losartan | 102 | $1,414 | $14 |
| Fenofibrate | 12 | $1,340 | $112 |
| Simvastatin | 97 | $1,310 | $14 |
| Omeprazole | 76 | $1,243 | $16 |
| Montelukast | 53 | $1,186 | $22 |
| Pantoprazole | 62 | $1,127 | $18 |
| Venlafaxine Hcl Er | 34 | $875 | $26 |
| Allopurinol | 50 | $855 | $17 |
| Clopidogrel | 33 | $795 | $24 |
| Testosterone Cypionate | 30 | $785 | $26 |
| Metoprolol | 57 | $734 | $13 |
| Glimepiride | 33 | $721 | $22 |
| Atenolol | 97 | $672 | $7 |
| Trazodone | 68 | $666 | $10 |
| Metformin | 50 | $654 | $13 |
| Balsalazide Disodium | 12 | $620 | $52 |
| Sertraline | 43 | $604 | $14 |
| Tamsulosin | 30 | $521 | $17 |
| Alprazolam | 75 | $510 | $7 |
| Fluticasone Propionate | 32 | $473 | $15 |
| Doxycycline Hyclate | 22 | $468 | $21 |
| Hydrochlorothiazide | 119 | $460 | $4 |
| Methylprednisolone | 32 | $405 | $13 |
| Carvedilol | 24 | $383 | $16 |
| Potassium Chloride | 17 | $376 | $22 |
| Bupropion Xl | 15 | $365 | $24 |
| Citalopram Hbr | 50 | $336 | $7 |
| Hydroxyzine | 12 | $301 | $25 |
| Duloxetine | 11 | $257 | $23 |
| Finasteride | 15 | $243 | $16 |
| Escitalopram | 14 | $224 | $16 |
| Lovastatin | 11 | $224 | $20 |
| Paxlovid (Eua) | 20 | $214 | $11 |
| Warfarin | 37 | $211 | $6 |
| Losartan-Hydrochlorothiazide | 13 | $199 | $15 |
| Amoxicillin-Clavulanate Potass | 24 | $197 | $8 |
| Paroxetine | 15 | $194 | $13 |
| Triamcinolone Acetonide | 18 | $184 | $10 |
| Ciprofloxacin | 17 | $176 | $10 |
| Furosemide | 50 | $166 | $3 |
| Tramadol | 39 | $164 | $4 |
| Clonidine | 12 | $147 | $12 |
| Clonazepam | 27 | $144 | $5 |
| Lorazepam | 25 | $131 | $5 |
| Ibuprofen | 30 | $127 | $4 |
| Prednisone | 48 | $126 | $3 |
| Azithromycin | 27 | $124 | $5 |
| Cyclobenzaprine | 28 | $103 | $4 |
| Sulfamethoxazole-Trimethoprim | 13 | $79 | $6 |
| Sildenafil Citrate | 13 | $22 | $2 |
2022: 68 drugs
| Jardiance | 18 | $25,153 | $1,397 |
| Trulicity | 15 | $23,137 | $1,542 |
| Xarelto | 16 | $21,425 | $1,339 |
| Eliquis | 15 | $18,256 | $1,217 |
| Januvia | 11 | $10,437 | $949 |
| Symbicort | 15 | $8,851 | $590 |
| Atorvastatin | 309 | $4,959 | $16 |
| Metoprolol | 128 | $3,095 | $24 |
| Pravastatin | 123 | $2,644 | $21 |
| Ezetimibe | 36 | $2,618 | $73 |
| Rosuvastatin | 86 | $2,379 | $28 |
| Metformin Hcl Er | 92 | $1,752 | $19 |
| Albuterol Sulfate Hfa | 39 | $1,619 | $42 |
| Amlodipine Besylate | 148 | $1,569 | $11 |
| Levothyroxine | 92 | $1,471 | $16 |
| Benazepril | 119 | $1,469 | $12 |
| Lisinopril | 205 | $1,418 | $7 |
| Losartan | 104 | $1,417 | $14 |
| Emtricitabine-Tenofovir Disop | 20 | $1,354 | $68 |
| Omeprazole | 67 | $1,297 | $19 |
| Pantoprazole | 60 | $1,176 | $20 |
| Testosterone Cypionate | 29 | $1,139 | $39 |
| Glimepiride | 51 | $1,090 | $21 |
| Atenolol | 114 | $996 | $9 |
| Gabapentin | 42 | $928 | $22 |
| Clopidogrel | 30 | $783 | $26 |
| Trazodone | 58 | $674 | $12 |
| Simvastatin | 62 | $633 | $10 |
| Venlafaxine Hcl Er | 19 | $622 | $33 |
| Metformin | 63 | $558 | $9 |
| Fluticasone Propionate | 35 | $553 | $16 |
| Warfarin | 43 | $552 | $13 |
| Hydrochlorothiazide | 132 | $549 | $4 |
| Montelukast | 31 | $547 | $18 |
| Metoprolol | 72 | $529 | $7 |
| Sertraline | 43 | $528 | $12 |
| Citalopram Hbr | 46 | $487 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $415 | $32 |
| Lovastatin | 28 | $402 | $14 |
| Allopurinol | 25 | $399 | $16 |
| Fluoxetine | 12 | $392 | $33 |
| Methylprednisolone | 35 | $375 | $11 |
| Mirtazapine | 12 | $374 | $31 |
| Doxycycline Hyclate | 19 | $344 | $18 |
| Potassium Chloride | 19 | $339 | $18 |
| Amoxicillin-Clavulanate Potass | 19 | $310 | $16 |
| Olmesartan Medoxomil | 11 | $305 | $28 |
| Furosemide | 53 | $294 | $6 |
| Escitalopram | 12 | $285 | $24 |
| Tamsulosin | 13 | $269 | $21 |
| Valsartan | 11 | $266 | $24 |
| Carvedilol | 14 | $224 | $16 |
| Paxlovid (Eua) | 18 | $196 | $11 |
| Diltiazem 24hr Er (Cd) | 11 | $190 | $17 |
| Azithromycin | 25 | $152 | $6 |
| Paroxetine | 12 | $150 | $13 |
| Alprazolam | 48 | $142 | $3 |
| Isosorbide Mononitrate Er | 11 | $134 | $12 |
| Clonazepam | 22 | $124 | $6 |
| Ibuprofen | 26 | $122 | $5 |
| Ciprofloxacin | 17 | $121 | $7 |
| Cyclobenzaprine | 23 | $112 | $5 |
| Lorazepam | 23 | $107 | $5 |
| Donepezil | 11 | $99 | $9 |
| Tramadol | 22 | $60 | $3 |
| Zolpidem | 12 | $57 | $5 |
| Cephalexin | 12 | $38 | $3 |
| Sildenafil Citrate | 11 | $19 | $2 |
2021: 44 drugs
| Jardiance | 16 | $20,185 | $1,262 |
| Atorvastatin | 132 | $2,939 | $22 |
| Metoprolol | 70 | $2,002 | $29 |
| Rosuvastatin | 42 | $1,663 | $40 |
| Albuterol Sulfate Hfa | 20 | $1,340 | $67 |
| Pravastatin | 63 | $1,274 | $20 |
| Ezetimibe | 15 | $1,273 | $85 |
| Pantoprazole | 27 | $1,047 | $39 |
| Lisinopril | 119 | $986 | $8 |
| Amlodipine Besylate | 71 | $808 | $11 |
| Benazepril | 60 | $725 | $12 |
| Losartan | 35 | $658 | $19 |
| Metformin Hcl Er | 29 | $658 | $23 |
| Levothyroxine | 24 | $578 | $24 |
| Atenolol | 54 | $547 | $10 |
| Citalopram Hbr | 35 | $511 | $15 |
| Diclofenac | 17 | $481 | $28 |
| Glimepiride | 21 | $467 | $22 |
| Gabapentin | 14 | $461 | $33 |
| Fluticasone Propionate | 29 | $445 | $15 |
| Omeprazole | 29 | $440 | $15 |
| Allopurinol | 19 | $439 | $23 |
| Doxycycline Hyclate | 19 | $430 | $23 |
| Metformin | 31 | $397 | $13 |
| Montelukast | 16 | $394 | $25 |
| Lovastatin | 14 | $363 | $26 |
| Methylprednisolone | 23 | $329 | $14 |
| Metoprolol | 39 | $327 | $8 |
| Simvastatin | 37 | $325 | $9 |
| Warfarin | 13 | $292 | $22 |
| Clopidogrel | 13 | $284 | $22 |
| Trazodone | 28 | $263 | $9 |
| Nitrofurantoin Mono-Macro | 17 | $255 | $15 |
| Hydrochlorothiazide | 51 | $246 | $5 |
| Sertraline | 14 | $244 | $17 |
| Amoxicillin-Clavulanate Potass | 15 | $233 | $16 |
| Furosemide | 35 | $197 | $6 |
| Ciprofloxacin | 14 | $129 | $9 |
| Ibuprofen | 19 | $115 | $6 |
| Azithromycin | 17 | $114 | $7 |
| Clonazepam | 11 | $109 | $10 |
| Alprazolam | 25 | $79 | $3 |
| Cyclobenzaprine | 13 | $51 | $4 |
| Tramadol | 18 | $36 | $2 |
Money from drug and device companies
$2,091 in 2025
| 2025 | 16 | 98 | None | $2,091 |
| 2024 | 13 | 61 | None | $1,150 |
| 2023 | 8 | 28 | None | $520 |
| 2022 | 3 | 8 | None | $121 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $561 | 26 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $387 | 17 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $237 | 14 payments
|
| Lilly USA | Jardiance | $190 | 9 payments
|
| Lundbeck | Rexulti | $104 | 5 payments
|
| Novo Nordisk | Wegovy | $102 | 5 payments
|
See all 98 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-17 | Caplyta | $12 |
| Abbvie | Meals · 2025-12-15 | Qulipta | $35 |
| GlaxoSmithKline | Meals · 2025-12-04 | Shingrix | $17 |
| Novo Nordisk | Meals · 2025-12-03 | Wegovy | $17 |
| Olympus America | Meals · 2025-12-03 | Itind System | $23 |
| Axsome Therapeutics | Meals · 2025-11-20 | Auvelity | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-19 | Airsupra | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-19 | Caplyta | $11 |
| Abbvie | Meals · 2025-11-14 | Ubrelvy | $16 |
| Abbvie | Meals · 2025-11-13 | Vraylar | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-12 | Breztri | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-12 | Caplyta | $82 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-06 | Airsupra | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-05 | Caplyta | $11 |
| Lilly USA | Meals · 2025-11-04 | Jardiance | $29 |
| Novo Nordisk | Meals · 2025-10-30 | Wegovy | $19 |
| Abbvie | Meals · 2025-10-29 | Qulipta | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-16 | Caplyta | $30 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-15 | Caplyta | $10 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-09 | Caplyta | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-02 | Breztri | $23 |
| Lilly USA | Meals · 2025-10-01 | Mounjaro | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-30 | Caplyta | $6 |
| Abbvie | Meals · 2025-09-25 | Ubrelvy | $27 |
| Exact Sciences | Meals · 2025-09-25 | The Cologuard Plus Collection Kit | $26 |
| Lilly USA | Meals · 2025-09-24 | Kisunla | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-18 | Airsupra | $24 |
| Abbvie | Meals · 2025-09-17 | Vraylar | $30 |
| Lilly USA | Meals · 2025-09-11 | Mounjaro | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-10 | Breztri | $33 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-09 | Caplyta | $8 |
| Abbvie | Meals · 2025-09-05 | Qulipta | $26 |
| Lundbeck | Meals · 2025-09-05 | Rexulti | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-04 | Airsupra | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-27 | None | $23 |
| Amgen | Meals · 2025-08-21 | Otezla | $24 |
| Pfizer | Meals · 2025-08-20 | Nurtec Odt | $24 |
| Amgen | Meals · 2025-08-19 | Otezla | $26 |
| Axsome Therapeutics | Meals · 2025-08-07 | Auvelity | $30 |
| Lundbeck | Meals · 2025-08-06 | Rexulti | $22 |
| Abbvie | Meals · 2025-07-30 | Qulipta | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-24 | Caplyta | $21 |
| Merck Sharp & Dohme | Meals · 2025-07-23 | Capvaxive | $25 |
| Olympus America | Meals · 2025-07-22 | Itind System | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-22 | Caplyta | $8 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-22 | Caplyta | $2 |
| Novo Nordisk | Meals · 2025-07-16 | Rybelsus | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-10 | Airsupra | $26 |
| Pfizer | Meals · 2025-07-09 | Nurtec Odt | $29 |
| Lilly USA | Meals · 2025-07-08 | Kisunla | $20 |
| Pfizer | Meals · 2025-07-03 | Nurtec Odt | $19 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-03 | Caplyta | $10 |
| Novo Nordisk | Meals · 2025-06-26 | Rybelsus | $18 |
| Pfizer | Meals · 2025-06-25 | Nurtec Odt | $27 |
| Abbvie | Meals · 2025-06-24 | Vraylar | $21 |
| Lilly USA | Meals · 2025-06-19 | Jardiance | $19 |
| Abbvie | Meals · 2025-06-12 | Ubrelvy | $32 |
| Abbvie | Meals · 2025-06-11 | Vraylar | $19 |
| Amgen | Meals · 2025-06-10 | Otezla | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Airsupra | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-04 | Breztri | $22 |
| Abbvie | Meals · 2025-06-03 | Qulipta | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-29 | Breztri | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-29 | Breztri | $2 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-21 | Caplyta | $19 |
| Abbvie | Meals · 2025-05-15 | Vraylar | $6 |
| Abbvie | Meals · 2025-05-15 | Ubrelvy | $30 |
| Abbvie | Meals · 2025-04-24 | Vraylar | $7 |
| Lundbeck | Meals · 2025-04-24 | Rexulti | $22 |
| Abbvie | Meals · 2025-04-23 | Vraylar | $10 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-23 | Farxiga | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-17 | Breztri | $28 |
| Paratek Pharmaceuticals | Meals · 2025-04-16 | Nuzyra | $21 |
| Abbvie | Meals · 2025-04-10 | Vraylar | $8 |
| Lilly USA | Meals · 2025-04-09 | Kisunla | $20 |
| Abbvie | Meals · 2025-04-08 | Ubrelvy | $17 |
| Axsome Therapeutics | Meals · 2025-04-03 | Auvelity | $25 |
| Lundbeck | Meals · 2025-04-02 | Rexulti | $20 |
| Paratek Pharmaceuticals | Meals · 2025-03-27 | Nuzyra | $18 |
| Exact Sciences | Meals · 2025-03-26 | Cologuard Collection Kit | $15 |
| Novo Nordisk | Meals · 2025-03-20 | Wegovy | $23 |
| Lilly USA | Meals · 2025-03-19 | Mounjaro | $16 |
| Abbvie | Meals · 2025-03-18 | Ubrelvy | $21 |
| Abbvie | Meals · 2025-03-13 | Vraylar | $8 |
| Merck Sharp & Dohme | Meals · 2025-03-12 | Proquad | $23 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-05 | Jardiance | $21 |
| Abbvie | Meals · 2025-02-26 | Vraylar | $19 |
| Abbvie | Meals · 2025-02-14 | Ubrelvy | $24 |
| Abbvie | Meals · 2025-02-12 | Qulipta | $16 |
| Abbvie | Meals · 2025-02-10 | Qulipta | $30 |
| Lilly USA | Meals · 2025-02-07 | Jardiance | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-05 | Farxiga | $19 |
| Abbvie | Meals · 2025-02-01 | Ubrelvy | $15 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-30 | Trintellix | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-23 | Breztri | $21 |
| Lundbeck | Meals · 2025-01-08 | Rexulti | $25 |
| Abbvie | Meals · 2025-01-04 | Qulipta | $31 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-03 | Trintellix | $29 |
See earlier years (2024, 2023, 2022)
2024: $1,150
| Abbvie | Ubrelvy | $476 | 26 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $172 | 10 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $93 | 4 payments
|
| Lilly USA | Mounjaro | $67 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $65 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $57 | 2 payments
|
| Novo Nordisk | Wegovy | $55 | 3 payments
|
| Pfizer | Nurtec Odt | $52 | 3 payments
|
| Lundbeck | Brintellix | $47 | 2 payments
|
| Merck Sharp & Dohme | Gardasil | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| Teva Pharmaceuticals USA | Ajovy | $15 | 1 payment
|
| Echosens North America | Fibroscan | $15 | 1 payment
|
2023: $520
| Abbvie | Vraylar | $228 | 15 payments
|
| Lilly USA | Mounjaro | $75 | 4 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $63 | 3 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $47 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Breztri | $43 | 2 payments
|
| Teva Pharmaceuticals USA | Ajovy | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Pfizer | Comirnaty | $19 | 1 payment
|
2022: $121
| Abbvie | Ubrelvy | $66 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $39 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $17 | 1 payment
|
Professional record
- NPI
- 1760001770
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 159 N Broadway, Salem, NH, 03079
- NPI first listed
- 2020-04-09
- NPI last updated
- 2021-04-08
- NPI record certified
- 2021-04-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 6967 Sessions Dr, San Jose, CA, 95119